- US-listed companies
- Bionano Genomics, Inc.
- Balance sheet
Bionano Genomics, Inc.【BNGO】Balance sheet
Market cap
$3.73M
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 17 | 17 | 38 | 25 | 5 | 18 | 10 |
| Marketable securities, current | - | - | - | 226 | 108 | 49 | 0 |
| Total cash & short-term investments | 17 | 17 | 38 | 251 | 114 | 67 | 10 |
| Accounts receivable, net | 5 | 6 | 3 | 5 | 7 | 9 | 5 |
| Inventories | 1 | 3 | 3 | 12 | 30 | - | - |
| Total current assets | 23 | 28 | 47 | 272 | 157 | 140 | 39 |
| Property, plant and equipment, net | 2 | 2 | 5 | 10 | 18 | 23 | 19 |
| Total non-current assets | 2 | 2 | 14 | 105 | 150 | 74 | 37 |
| Total assets | 25 | 30 | 60 | 377 | 308 | 214 | 77 |
| Accounts payable | 1 | 3 | 3 | 10 | 13 | 10 | 7 |
| Long-term debt, current | - | 20 | - | - | - | - | - |
| Total current liabilities | 5 | 26 | 9 | 22 | 36 | 100 | 37 |
| Long-term debt, non-current | 9 | - | 16 | - | - | - | - |
| Total non-current liabilities | 10 | 227,127 | 16 | 18 | 22 | 18 | 4 |
| Total liabilities | 15 | 27 | 25 | 40 | 58 | 118 | 41 |
| Common stock and paid-in capital | 1,004 | 3,427 | 19,000 | 0 | 0 | 0 | - |
| Retained earnings | -72,762,428 | -102,577,498 | -143,683,849 | -216 | -349 | -581 | -693 |
| Stockholders' equity | 10 | 4 | 35 | 337 | 249 | 96 | 35 |
| Total debt | 9 | 20 | 16 | - | - | - | - |
| Net debt | -7,493,355 | 3 | -22 | - | - | - | - |
| D/E ratio (%) | 89.1 | 555.8 | 46.5 | - | - | - | - |
| Working capital | - | - |